Comparative analysis of Indian and foreign population for cervical cancer

Cervical cancer remains a significant global health challenge, with a particularly high prevalence inlow- and middle-income countries, such as India. This report investigates disparities in cervical cancerincidence, risk factors, screening methodologies, and treatment outcomes between India anddeveloped nations, aiming to identify key differences and suggest strategies for enhancing cervicalcancer control in resource-limited settings. A multi-faceted methodology was employed, includingan extensive literature review, data extraction from major health databases, surveys, and an analysisof reports from governmental and non-governmental organizations. The study applied descriptiveand comparative statistical methods, trend analysis, and thematic analysis to comprehensivelyevaluate the data. Results indicate that India experiences markedly higher cervical cancer incidenceand mortality compared to developed countries. Contributing factors include suboptimal HPVvaccination coverage, insufficient Pap smear screening, and regional variability in treatment options.In contrast, developed nations benefit from widespread HPV vaccination and robust screeningprograms, leading to lower cervical cancer rates and improved patient outcomes. The reportunderscores the need for strengthening prevention strategies in India by increasing HPV vaccinationrates and expanding access to screening and treatment. Addressing these deficiencies is essential forreducing the burden of cervical cancer and enhancing patient outcomes in India.